AR and prostate cancer: Having demonstrated that Thio-2 inhibits AR signaling and the growth of prostate cancer models independent of BAG-1 isoform function, we investigated whether its mechanism of action may be mediated through the AR NTD as it has previously been shown to inhibit AR NTD transactivation (15).